Track LeMaitre Vascular, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

LeMaitre Vascular, Inc. LMAT · Stock Open LeMaitre Vascular, Inc. in new tab

78.29 USD
P/E
29.41
EPS
2.75
Yield
1.16%
Safety Score
100
P/B
4.28
ROE
15.62
Beta
0.49
Target Price
100.43 USD
LeMaitre Vascular, Inc. logo

LeMaitre Vascular, Inc.

🧾 Earnings Recap – Q3 2026

LeMaitre shares fell 5.0% after earnings, despite 12% organic sales growth. The likely concern is the cost of growth: operating expenses rose 18%, faster than sales, while full-year guidance calls for 11% organic growth—below Q3’s pace.

  • Q3 organic sales grew 12%, comprising 7% price and 5% unit growth; reported sales growth was 11%, including a $440,000 negative FX impact.
  • Gross margin was 71.7%, up 90 basis points year over year; excluding a $0.5 million inventory reserve tied to the FAS-TIP discontinuation, it was 72.4%, up 160 basis points.
  • Operating expenses increased 18% to $31 million, with rep count up 13% to 171 and R&D spending up $1.1 million year over year. Operating margin was 26%.
  • Net income was $15 million and diluted EPS was $0.65. Free cash flow was $19.7 million, and cash and investments totaled $390 million at quarter-end.
  • Full-year guidance implies 11% organic sales growth and 18% EPS growth. LeMaitre also acquired B. Braun vascular assets for $19.2 million, including a portfolio with $9.4 million in 2025 sales.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 24, 2027
P/E29.41
EPS2.75
Book Value18.89
Price to Book4.28
Debt/Equity43.70
% Insiders6.521%
Growth
Revenue Growth0.11%
Earnings Growth-0.14%
Estimates
Forward P/E25.68
Forward EPS3.15
Target Mean Price100.43
Dividend
Dividend Yield1.16%
Annual dividends0.95 USD
Ex-Div. DateNov. 19, 2026
Payout34.23%
5y avg Yield0.87%

DCF valuation

Model fair value for LeMaitre Vascular, Inc. (LMAT)
Result
Sign in to run the valuation for LMAT.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
7 analysts · consensus Buy · mean target 100.43 USD (low 81.00, high 132.00) · as of 9 Nov 2026
Low 81.00
Mean 100.43
High 132.00
Price 78.29
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

LeMaitre Vascular, Inc. Logo LeMaitre Vascular, Inc. Analysis (LMAT)

United States Health Care Official Website Stock

Is LeMaitre Vascular, Inc. a good investment? LeMaitre Vascular, Inc. (LMAT) is currently trading at 78.29 USD. Market analysts have a consensus price target of 100.43 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 29.41. This valuation is generally in line with the broader market.

Earnings Schedule: LeMaitre Vascular, Inc. is expected to release its next earnings report on Feb. 24, 2027. The market consensus estimate for Forward EPS is 3.15.

For income investors, LeMaitre Vascular, Inc. pays a dividend yield of 1.16%. With a payout ratio of 34%, the dividend appears sustainable.

Investor FAQ

Does LeMaitre Vascular, Inc. pay a dividend?

Yes, it pays an annual dividend of 0.95 USD (1.16% yield).

What asset class is LeMaitre Vascular, Inc.?

LeMaitre Vascular, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 24, 2027. The company currently has a trailing EPS of 2.75.

Company Profile

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Exchange Ticker
NMS (United States) LMAT
FRA (Germany) LHU.F
Trades
Dividend Yield
1.16%
5y avg 0.87%
Annual Dividends
0.95USD
Next Ex. Div Date
Nov. 19, 2026
Payout Ratio
34.23%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2027
0.86 USD
Sept. 2, 2027 (estimated) 0.2868
June 3, 2027 (estimated) 0.2845
March 4, 2027 (estimated) 0.2848
▸2026
1.00 USD
Dec. 3, 2026 0.2500
Sept. 3, 2026 0.2500
June 4, 2026 0.2500
March 26, 2026 0.2500
▸2025
0.80 USD
Dec. 4, 2025 0.2000
Sept. 4, 2025 0.2000
May 29, 2025 0.2000
March 27, 2025 0.2000
▸2024
0.64 USD
Dec. 5, 2024 0.1600
Aug. 29, 2024 0.1600
May 30, 2024 0.1600
March 28, 2024 0.1600
▸2023
0.56 USD
Nov. 30, 2023 0.1400
Aug. 31, 2023 0.1400
June 1, 2023 0.1400
March 23, 2023 0.1400
▸2022
0.50 USD
Dec. 1, 2022 0.1250
Sept. 8, 2022 0.1250
June 2, 2022 0.1250
March 24, 2022 0.1250
▸2021
0.44 USD
Dec. 2, 2021 0.1100
Sept. 9, 2021 0.1100
June 3, 2021 0.1100
March 25, 2021 0.1100
▸2020
0.38 USD
Dec. 3, 2020 0.0950
Sept. 10, 2020 0.0950
June 4, 2020 0.0950
March 19, 2020 0.0950
▸2019
0.34 USD
Dec. 5, 2019 0.0850
Sept. 5, 2019 0.0850
June 6, 2019 0.0850
April 5, 2019 0.0850
▸2018
0.28 USD
Dec. 6, 2018 0.0700
Sept. 6, 2018 0.0700
June 7, 2018 0.0700
April 5, 2018 0.0700
▸2017
0.22 USD
Dec. 7, 2017 0.0550
Sept. 7, 2017 0.0550
June 8, 2017 0.0550
April 6, 2017 0.0550
▸2016
0.18 USD
Dec. 5, 2016 0.0450
Sept. 6, 2016 0.0450
June 8, 2016 0.0450
April 4, 2016 0.0450
▸2015
0.16 USD
Dec. 4, 2015 0.0400
Sept. 3, 2015 0.0400
June 5, 2015 0.0400
April 3, 2015 0.0400
▸2014
0.14 USD
Dec. 4, 2014 0.0350
Sept. 4, 2014 0.0350
June 5, 2014 0.0350
April 3, 2014 0.0350
▸2013
0.12 USD
Dec. 4, 2013 0.0300
Sept. 4, 2013 0.0300
June 5, 2013 0.0300
April 3, 2013 0.0300
▸2012
0.10 USD
Dec. 4, 2012 0.0250
Sept. 4, 2012 0.0250
June 4, 2012 0.0250
April 3, 2012 0.0250
▸2011
0.08 USD
Dec. 6, 2011 0.0200
Sept. 6, 2011 0.0200
June 6, 2011 0.0200
April 5, 2011 0.0200
Upcoming Dividends
Name Payment Date Status Amount
LeMaitre Vascular, Inc. Dec 03, 2026 Upcoming 0.25 USD
LeMaitre Vascular, Inc. Sep 03, 2026 0.25 USD
LeMaitre Vascular, Inc. Jun 04, 2026 0.25 USD
LeMaitre Vascular, Inc. Mar 26, 2026 0.25 USD
LeMaitre Vascular, Inc. Dec 04, 2025 0.2 USD
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion